Watchman Group, Inc. Abbott Laboratories Transaction History

Watchman Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $187,777 - $221,040	-1,775 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $38,747 - $45,649	-356 Reduced 16.71%	1,775 $213,000
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $21,000 - $22,884	-200 Reduced 8.58%	2,131 $233,000
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $91,640 - $111,290	-1,000 Reduced 30.02%	2,331 $254,000
Q2 2020 Jul 07, 2020	SELL	$76.57 - $98.0 $7,656 - $9,800	-100 Reduced 2.91%	3,331 $305,000
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $6,282 - $9,186	100 Added 3.0%	3,431 $271,000
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $261,516 - $291,129	3,331 New	3,331 $289,000

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Watchman Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Watchman Group, Inc. with notifications on news.